NPI registry status
Active
2026 NPPES data Oncology Pharmacist NPI 1013792522 PHARMD.
Verify on CMS → Justin Colucci, PHARMD.
Oncology Pharmacist in Santa Rosa, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,916 in Oncology Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
28
Medicare Part D claims · 23 beneficiaries · Oncology Pharmacist avg: 157
Generic prescribing
0%
generic claims · 71% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Justin Colucci, PHARMD. filed 28 Medicare Part D claims in 2024 as an Oncology Pharmacist in Santa Rosa, California, prescribing 0% generic.
- 28
- Part D claims, 2024
- 0%
- generic prescribing
- ≥0th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Justin Colucci, PHARMD.
Bare NPI registry listing — limited federal enrichment beyond basic enumeration. Verify all credentials with official sources.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1013792522), first enumerated 08/31/2023.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 28 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Justin Colucci, PHARMD.'s individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1013792522 · Oncology Pharmacist
NPI-10 · ENUM-RECENT · TAX-NARROW · RX-TRACE · BOOK-THIN · PHOTO-ENUM
- NPI-10 1013792522
- ENUM-RECENT 2023
- TAX-NARROW 1,916
- RX-TRACE 28
- BOOK-THIN 265 in California
- PHOTO-ENUM Tiffany Tam, PHARMD · 2023
Justin Colucci, PHARMD.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
28 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Justin Colucci, PHARMD.?
Quality data not reportedPrimary specialty
Oncology Pharmacist
Medicare Part D claims
28 82% vs specialty avg
Specialty distribution in California
How Oncology Pharmacist compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Oncology Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1013792522 |
|---|---|
| Specialty | Oncology Pharmacist |
| Credentials | PHARMD. |
| Gender | Male |
| NPI Issued | 08/31/2023 |
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Justin Colucci, PHARMD.. To verify Justin Colucci, PHARMD.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Justin Colucci, PHARMD. - brand share 71.0%
Oncology Pharmacist average
71% brand-name claims vs 0% generic, on 28 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
28
Total Claims
$333K
Total Drug Cost
23
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 36.667
- Total Day Supply
- 1,078
- Brand vs Generic
- 71% brand / 0% generic
- Brand Drug Cost
- $332K
Patient Demographics
- Average Patient Age
- 76.3 years
- Avg HCC Risk Score
- 3.12
Oncology Pharmacist Overview
How Justin Colucci, PHARMD. fits within the Oncology Pharmacist landscape nationally.
1,916
Oncology Pharmacist Providers in US
51
States with Oncology Pharmacist
157
Avg Claims per Provider
Justin Colucci, PHARMD.'s 28 claims are below the specialty average of 157.
Nationwide Oncology Pharmacist peers with similar MIPS or enrollment year
Two federal-record peer sets for Colucci, both outside California so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2023)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Oncology Pharmacist Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Colucci.
One of 265 Oncology Pharmacist providers enrolled in California, 5 are shown here.
Dr. Jayrom Acorda
PHARM.D.
Palm Springs, CA
Dr. Antonio Acuna
PHARMD
San Diego, CA
Dr. Leena Agrawal
PHARMD
Santa Rosa, CA
Dr. Artemio Alanis
PHARMD
Fairfield, CA
Dr. Prasannaraddi Alavandi
PHARMD
Palo Alto, CA
Compare Oncology Pharmacist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Justin Colucci, PHARMD.'s specialty? ▼
Justin Colucci, PHARMD. specializes in Oncology Pharmacist and practices in Santa Rosa, California. Credentials: PHARMD..
How much does Justin Colucci, PHARMD. prescribe under Medicare Part D? ▼
In 2024, Justin Colucci, PHARMD. wrote 28 Medicare Part D claims totaling $333K in drug costs for 23 beneficiaries.
Where is Justin Colucci, PHARMD. located? ▼
Justin Colucci, PHARMD. is located at 401 BICENTENNIAL WAY, Santa Rosa, CA, 95403. Phone: (707) 393-4119.
What is Justin Colucci, PHARMD.'s NPI number? ▼
Justin Colucci, PHARMD.'s National Provider Identifier (NPI) is 1013792522, issued on 08/31/2023.
Does Justin Colucci, PHARMD. prescribe more brand-name or generic drugs? ▼
Justin Colucci, PHARMD.'s prescribing is 71% brand-name and 0% generic drugs by claim count, with $332K in brand drug costs.
How many Oncology Pharmacist providers are there in the US? ▼
There are 1,916 Oncology Pharmacist providers across 51 states in the US. The average Oncology Pharmacist provider writes 157 Medicare Part D claims per year.
Does Justin Colucci, PHARMD. accept Medicare? ▼
Justin Colucci, PHARMD. appears in CMS Medicare data with 28 Part D claims and 23 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Justin Colucci, PHARMD.'s credentials? ▼
Justin Colucci, PHARMD.'s NPI is 1013792522 with credentials PHARMD.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.